Fengmin Shao

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients

Jinlan Zhang, Yuhuan Li, Lulu Wang et al. · Signal Transduction and Targeted Therapy · 2021 · 206 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation

Lei Yan, Guang‐Hui Liu, Huixia Cao et al. · Biochemical and Biophysical Research Communications · 2019 · 84 citations · Full text

Medicine, Cancer Biology, Oncology +14

LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma

Yanliang Wang, Yuchen Feng, Yujin Gan et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 71 citations · Full text

Medicine, Molecular Biology, Oncology +17